Checkpoint blockade: a concept or already a reality?
Checkpoint blockade: a concept or already a reality?
Emerging pathways in immunotherapy
Upcoming trends in myeloma therapy
Recent advances in mantle cell lymphoma: Expert panel discussion
Lecture: Current use of systemic therapies in localised disease
Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients?
Lecture: Future strategies and targets for prostate cancer
Rituximab versus idelalisib in refractory CLL
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients
WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies
Intratumour heterogeneity in renal and lung cancer
Kidney cancer treatment ten years from now